Surescripts Buys Messaging Partner Kryptiq
National electronic prescribing network operator Surescripts has acquired clinical messaging software vendor Kryptiq Corp. for an undisclosed sum.
National electronic prescribing network operator Surescripts has acquired clinical messaging software vendor Kryptiq Corp. for an undisclosed sum.
The companies have not formally announced the acquisition, but Luis Machuca, CEO of Beaverton, Ore.-based Kryptiq, has talked to Oregon newspapers about the deal.
The companies have been partners for some time. Surescripts previously held about 21 percent of Kryptiq after investing in the company in late 2010 and using Kryptiq’s technology to launch the exchange of clinical information over its e-prescribing network.
Now, selling out to Surescripts gives Kryptiq more resources and provides a solid return for investors, Machuca told The Oregonian. He expects to continue running Kryptiq and retain all 125 employees. The company anticipates 2012 revenue of about $25 million.
The companies have not formally announced the acquisition, but Luis Machuca, CEO of Beaverton, Ore.-based Kryptiq, has talked to Oregon newspapers about the deal.
The companies have been partners for some time. Surescripts previously held about 21 percent of Kryptiq after investing in the company in late 2010 and using Kryptiq’s technology to launch the exchange of clinical information over its e-prescribing network.
Now, selling out to Surescripts gives Kryptiq more resources and provides a solid return for investors, Machuca told The Oregonian. He expects to continue running Kryptiq and retain all 125 employees. The company anticipates 2012 revenue of about $25 million.
More for you
Loading data for hdm_tax_topic #better-outcomes...